Enhancing Heart Function For Early Recovery Using Non-Blood Contacting Technology
OUR MISSION —
Pioneering non-blood contacting devices that enhance heart function and promote early recovery in adult & pediatric populations.
Refining the treatment of both diastolic and systolic heart failure.
MyST™ Technology
—
Enhancing Heart Function For Early Recovery
—
MyST™ Technology — Enhancing Heart Function For Early Recovery —
OUR TECHNOLOGY—
Extensive Patent Portfolio for Broad Technology Development
Our comprehensive patent portfolio encompasses a wide range of innovations aimed at enhancing cardiac function. These include advancements in drive system regulation, cardiac synchronization, diastolic & systolic myocardial strain augmentation, material dynamics, modular designs, and minimally invasive strategies. Our focus extends to both adult and pediatric populations for acute recovery of the failing heart.
MyST-I™ & Drive System
New Adult MyST-I™ Patented Design Cup and Drive System. Proven to augment diastolic & systolic pump function, promoting heart filling & emptying which leads to early healing and recovery.
MyST-II™
Patent figures for our minimally invasive technology.
Pediatric MyST-I™
Left: ECHO image of device on neonatal size heart. Arrows indicate diastolic strain (filling) augmentation. Right: Neonatal device with extensive laboratory investigations in the small heart.
* In-human pediatric experience with a patient supported for 7-1/2 days at age 18 who is alive & well with normal heart function today.
Inquiries?
Please contact Deb Conley, Managing Director